DC
IRWD icon

Deere & Company’s Ironwood Pharmaceuticals IRWD Stock Holding History

Deere & Company’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-38,416
Closed -$515K – 1047
2015
Q1 		$515K Hold
38,416
– – 0.03% 613
2014
Q4 		$493K Hold
38,416
– – 0.03% 615
2014
Q3 		$417K Buy
+38,416
New +$440K 0.02% 701

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Deere & Company's IRWD Position: Q2 2015 in Review

Deere & Company sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2015, closing a stake of 38,416 shares — an estimated $515K sold.

Deere & Company first reported a position in IRWD in Q3 2014 and held it in 3 quarters. The position peaked at $515K in Q1 2015. 137 funds tracked by Wall St. Rank hold IRWD as of Q2 2015.

  • Deere & Company reported no remaining Ironwood Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Deere & Company sold 38,416 Ironwood Pharmaceuticals shares in Q2 2015, an estimated $515K.
  • Deere & Company first reported a position in Ironwood Pharmaceuticals in Q3 2014 and held it in 3 quarters.
  • Deere & Company's Ironwood Pharmaceuticals position peaked at $515K in Q1 2015.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2015.

Based on Deere & Company's 13F filing for Q2 2015, filed 13 Aug 2015.